Komori
ispace (9348) · FactAnnual amount updated

Recognition of R&D expenses of ¥1,065.836 million

First written in FY2024-Q1. . Latest entry: FY2026.

8entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2024-Q1 – FY20262023: 220232024: 320242025: 220252026: 12026
Same theme, other companies
Decrease in R&D expensesA theme 50 companies write about · 46 as a headwind · 4 as a tailwind

42 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2026Annual amount updatedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥3,928.864 million.」

    Annual research and development expenses were disclosed. They decreased from ¥7,730.999 million in the previous fiscal year.
  2. FY2026-H1First-half cumulative amount disclosedAnnual report

    「Research and development expenses for the Group as a whole during the six months of the current consolidated fiscal year totaled ¥2,279.537 million.」

    The cumulative research and development expenses from April to September 2025 were disclosed.
  3. FY2025Annual amount disclosedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥7,730.999 million.」

    Annual research and development expenses were disclosed at ¥7,730.999 million, up from ¥3,834.408 million in the previous fiscal year.
  4. FY2025-H1First-half cumulative amount disclosedAnnual report

    「Research and development expenses for the Group as a whole during the six months of the current consolidated fiscal year totaled ¥2,203.046 million.」

    The cumulative research and development expenses from April to September 2024 were disclosed.
  5. FY2024Annual amount disclosedAnnual report

    「Total research and development expenses for the current consolidated fiscal year were ¥3,834.408 million.」

    The total annual research and development expenses were disclosed based on the quarterly cumulative amounts, showing the annual results of research and development investment related to Missions 2, 3 and 6, among others.
  6. FY2024-Q3Nine-month cumulative amount disclosedAnnual report

    「Research and development expenses for the Group as a whole during the first nine months of the current consolidated fiscal year totaled ¥2,697.162 million.」

    The cumulative research and development expenses for the third quarter were disclosed.
  7. FY2024-Q2First-half cumulative amount disclosedAnnual report

    「Research and development expenses for the Group as a whole during the first six months of the current consolidated fiscal year totaled ¥1,637.144 million.」

    The cumulative first-half research and development expenses were disclosed.
  8. FY2024-Q1First statedAnnual report

    「Research and development expenses for the Group as a whole during the first quarter of the current consolidated fiscal year totaled ¥1,065.836 million.」

    This was the first disclosure of the actual research and development investment for the quarter.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for ispace yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Recognition of R&D expenses of ¥1,065.836 million | ispace,inc. (9348) | Komori